Ryan Specialty Holdings, Inc. (NYSE:RYAN) Receives $74.40 Consensus Target Price from Analysts

Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) have been assigned a consensus rating of “Hold” from the twelve analysts that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and six have issued a buy recommendation on the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $74.40.

Several research analysts recently weighed in on the company. The Goldman Sachs Group increased their price objective on Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 9th. Barclays increased their price objective on Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, November 21st. BMO Capital Markets upgraded Ryan Specialty from a “market perform” rating to an “outperform” rating and lifted their target price for the company from $65.00 to $75.00 in a report on Tuesday, September 24th. Keefe, Bruyette & Woods decreased their target price on Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating for the company in a report on Friday, January 10th. Finally, Bank of America lifted their price target on Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a report on Thursday, October 10th.

Ryan Specialty Price Performance

Shares of Ryan Specialty stock opened at $66.57 on Friday. The business has a 50 day simple moving average of $67.84 and a two-hundred day simple moving average of $66.06. Ryan Specialty has a 12 month low of $42.21 and a 12 month high of $75.97. The stock has a market capitalization of $17.43 billion, a P/E ratio of 86.46, a PEG ratio of 1.12 and a beta of 0.72. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01.

Ryan Specialty (NYSE:RYAN) last announced its earnings results on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, meeting analysts’ consensus estimates of $0.41. The business had revenue of $604.69 million during the quarter, compared to analysts’ expectations of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The business’s revenue was up 20.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.32 earnings per share. As a group, analysts predict that Ryan Specialty will post 1.82 EPS for the current fiscal year.

Ryan Specialty Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th were issued a dividend of $0.11 per share. The ex-dividend date was Tuesday, November 12th. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.66%. Ryan Specialty’s payout ratio is 57.14%.

Insider Activity at Ryan Specialty

In other news, EVP Mark Stephen Katz sold 14,790 shares of Ryan Specialty stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the sale, the executive vice president now owns 12,386 shares of the company’s stock, valued at approximately $884,236.54. The trade was a 54.42 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director David P. Bolger sold 7,055 shares of Ryan Specialty stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $70.88, for a total value of $500,058.40. Following the sale, the director now directly owns 78,149 shares in the company, valued at approximately $5,539,201.12. This trade represents a 8.28 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 191,402 shares of company stock worth $12,762,989. Corporate insiders own 11.10% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in RYAN. Xponance Inc. boosted its stake in shares of Ryan Specialty by 67.2% during the 2nd quarter. Xponance Inc. now owns 20,686 shares of the company’s stock valued at $1,198,000 after buying an additional 8,312 shares during the period. Jennison Associates LLC increased its holdings in shares of Ryan Specialty by 60.2% during the 3rd quarter. Jennison Associates LLC now owns 1,025,063 shares of the company’s stock worth $68,054,000 after purchasing an additional 385,366 shares during the period. JPMorgan Chase & Co. increased its holdings in shares of Ryan Specialty by 107.5% during the 3rd quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company’s stock worth $30,504,000 after purchasing an additional 238,064 shares during the period. Geneva Partners LLC bought a new position in shares of Ryan Specialty during the 3rd quarter worth about $2,537,000. Finally, Bar Harbor Wealth Management increased its stake in Ryan Specialty by 5.9% in the fourth quarter. Bar Harbor Wealth Management now owns 168,871 shares of the company’s stock valued at $10,835,000 after acquiring an additional 9,482 shares during the period. Institutional investors and hedge funds own 84.82% of the company’s stock.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.